Dapiprazole

Dapiprazole

Clinical data
AHFS/Drugs.com	Consumer Drug Information
MedlinePlus	a601043
Pregnancy category	B
Routes of administration	Topical (eye drops)
ATC code	S01EX02 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	Negligible when administered topically
Identifiers
IUPAC name 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8- tetrahydro-[1,2,4]triazolo[4,5-a]pyridine
CAS Number	72822-12-9 Y
PubChem CID	3033538
DrugBank	DB00298 Y
ChemSpider	2298190 Y
UNII	5RNZ8GJO7K
KEGG	D07775 Y
ChEBI	CHEBI:51066 Y
ChEMBL	ChEMBL1201216 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C19H27N5
Molar mass	325.451 g/mol
3D model (JSmol)	Interactive image
SMILES n1nc(n2c1CCCC2)CCN4CCN(c3ccccc3C)CC4
InChI InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3 Y Key:RFWZESUMWJKKRN-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

WikiDoc Resources for Dapiprazole
Articles
Most recent articles on Dapiprazole Most cited articles on Dapiprazole Review articles on Dapiprazole Articles on Dapiprazole in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dapiprazole Images of Dapiprazole Photos of Dapiprazole Podcasts & MP3s on Dapiprazole Videos on Dapiprazole
Evidence Based Medicine
Cochrane Collaboration on Dapiprazole Bandolier on Dapiprazole TRIP on Dapiprazole
Clinical Trials
Ongoing Trials on Dapiprazole at Clinical Trials.gov Trial results on Dapiprazole Clinical Trials on Dapiprazole at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dapiprazole NICE Guidance on Dapiprazole NHS PRODIGY Guidance FDA on Dapiprazole CDC on Dapiprazole
Books
Books on Dapiprazole
News
Dapiprazole in the news Be alerted to news on Dapiprazole News trends on Dapiprazole
Commentary
Blogs on Dapiprazole
Definitions
Definitions of Dapiprazole
Patient Resources / Community
Patient resources on Dapiprazole Discussion groups on Dapiprazole Patient Handouts on Dapiprazole Directions to Hospitals Treating Dapiprazole Risk calculators and risk factors for Dapiprazole
Healthcare Provider Resources
Symptoms of Dapiprazole Causes & Risk Factors for Dapiprazole Diagnostic studies for Dapiprazole Treatment of Dapiprazole
Continuing Medical Education (CME)
CME Programs on Dapiprazole
International
Dapiprazole en Espanol Dapiprazole en Francais
Business
Dapiprazole in the Marketplace Patents on Dapiprazole
Experimental / Informatics
List of terms related to Dapiprazole

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dapiprazole (Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination.